Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years.
Major CK, Kantarjian H, Sasaki K, Borthakur G, Kadia T, Pemmaraju N, DiNardo C, Short NJ, Daver N, Jabbour E, Champlin R, Garcia-Manero G, Konopleva M, Andreeff M, Kornblau S, Wierda W, Pierce S, Ravandi F, Cortes J.
Major CK, et al.
Leuk Lymphoma. 2020 Dec;61(13):3120-3127. doi: 10.1080/10428194.2020.1802450. Epub 2020 Aug 5.
Leuk Lymphoma. 2020.
PMID: 32755333